Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial

CS Calfee, KL Delucchi, P Sinha… - The Lancet …, 2018 - thelancet.com
Background Precision medicine approaches that target patients on the basis of disease
subtype have transformed treatment approaches to cancer, asthma, and other …
被引用次数：560 相关文章

Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial

CS Calfee, KL Delucchi, P Sinha, MA Matthay… - 2018 - pubmed.ncbi.nlm.nih.gov
Background Precision medicine approaches that target patients on the basis of disease
subtype have transformed treatment approaches to cancer, asthma, and other …

Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.

CS Calfee, KL Delucchi, P Sinha… - The Lancet …, 2018 - escholarship.org
BackgroundPrecision medicine approaches that target patients on the basis of disease
subtype have transformed treatment approaches to cancer, asthma, and other …

[引用][C] Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial

SC Carolyn, LD Kevin, P Sinha, AM Michael… - THE LANCET …, 2018 - iris.hunimed.eu

Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial

CS Calfee, KL Delucchi, P Sinha… - The Lancet …, 2018 - pure.qub.ac.uk
Background Precision medicine approaches that target patients on the basis of disease
subtype have transformed treatment approaches to cancer, asthma, and other …

Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial

Irish Critical Care Trials Group - The Lancet Respiratory …, 2018 - profiles.wustl.edu
Background: Precision medicine approaches that target patients on the basis of disease
subtype have transformed treatment approaches to cancer, asthma, and other …

Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.

CS Calfee, KL Delucchi, P Sinha… - The Lancet …, 2018 - europepmc.org
Background Precision medicine approaches that target patients on the basis of disease
subtype have transformed treatment approaches to cancer, asthma, and other …

[引用][C] Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial

CS Calfee, KL Delucchi, P Sinha… - The Lancet …, 2018 - research.ed.ac.uk
Acute respiratory distress syndrome subphenotypes and differential response to simvastatin:
secondary analysis of a randomised controlled trial — University of Edinburgh Research …
[PDF] qub.ac.uk

[PDF][PDF] Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial

CS Calfee, KL Delucchi, P Sinha, MA Matthay… - 2018 - pureadmin.qub.ac.uk
Background: Precision medicine approaches targeting patients based on disease subtype
have transformed approaches to cancer, asthma, and other heterogeneous syndromes. Two …

Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: Secondary Analysis of a Randomized Controlled Trial

C Calfee, K Delucchi, P Sinha, M Matthay… - The lancet …, 2018 - kclpure.kcl.ac.uk
Background: Precision medicine approaches targeting patients based on disease subtype
have transformed approaches to cancer, asthma, and other heterogeneous syndromes. Two …